Evidence-Based Medicine Guidelines
Topical tacrolimus for atopic dermatitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topical Tacrolimus for Atopic Dermatitis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458510/0/_________Topical_tacrolimus_for_atopic_dermatitis______.
Topical tacrolimus for atopic dermatitis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/458510/0/_________Topical_tacrolimus_for_atopic_dermatitis______. Accessed April 9, 2025.
Topical tacrolimus for atopic dermatitis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/458510/0/_________Topical_tacrolimus_for_atopic_dermatitis______
Topical Tacrolimus for Atopic Dermatitis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458510/0/_________Topical_tacrolimus_for_atopic_dermatitis______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topical tacrolimus for atopic dermatitis
ID - 458510
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458510/0/_________Topical_tacrolimus_for_atopic_dermatitis______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
